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Abstract: Ergot alkaloids are pharmaceutically and agriculturally important secondary
metabolites produced by several species of fungi. Ergot alkaloid pathways vary among
different fungal lineages, but the pathway intermediate chanoclavine-I is evolutionarily
conserved among ergot alkaloid producers. At least four genes, dmaW, easF, easE, and
easC, are necessary for pathway steps prior to chanoclavine-I; however, the sufficiency of
these genes for chanoclavine-I synthesis has not been established. A fragment of genomic
DNA containing dmaW, easF, easE, and easC was amplified from the human-pathogenic,
ergot alkaloid-producing fungus Aspergillus fumigatus and transformed into
Aspergillus nidulans, a model fungus that does not contain any of the ergot alkaloid
synthesis genes. HPLC and LC-MS analyses demonstrated that transformed A. nidulans
strains produced chanoclavine-I and an earlier pathway intermediate. Aspergillus nidulans
transformants containing dmaW, easF, and either easE or easC did not produce
chanoclavine-I but did produce an early pathway intermediate and, in the case of the easC
transformant, an additional ergot alkaloid-like compound. We conclude that dmaW, easF,
easE, and easC are sufficient for the synthesis of chanoclavine-I in A. nidulans and
expressing ergot alkaloid pathway genes in A. nidulans provides a novel approach to
understanding the early steps in ergot alkaloid synthesis.
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1. Introduction
Ergot alkaloids are tryptophan-derived mycotoxins produced by several different fungi and have
proven to be both pharmaceutically and agriculturally important. Several Claviceps, Neotyphodium,
and Epichloë species of the order Hypocreales produce a variety of complex ergot alkaloids [1,2].
Aspergillus fumigatus and Penicillium commune of the order Eurotiales also are capable of ergot
alkaloid synthesis; however, their ergot alkaloid profiles differ considerably from those of the
Hypocrealean ergot alkaloid producers [2,3]. Ergot alkaloid-producing fungi contain an ergot alkaloid
synthesis (eas) gene cluster with a set of core genes that is well conserved [1–4]. The eas clusters of
the various ergot alkaloid producers also contain variable, lineage-specific genes that result in the
formation of different pathway products among lineages [2,4]. The steps of ergot alkaloid synthesis
leading to the formation of chanoclavine-I (the earliest ergot alkaloid pathway biosynthetic
intermediate observed accumulating in most producers) (Figure 1) are believed to be evolutionarily
conserved among the different fungi that produce ergot alkaloids [1–4]; however, the identity and
catalytic activities of all the genes required for chanoclavine-I synthesis have not yet been determined.
Figure 1. Early steps of the ergot alkaloid pathway. Genes controlling specific
steps are listed beside arrows. Abbreviations: DMAPP = dimethylallyldiphosphate;
Trp = tryptophan; DMAT = dimethylallyltryptophan. Unresolved steps are indicated in red.

Based on the proposed biochemical scheme of Kozikowski et al. [5], the synthesis of
chanoclavine-I occurs in at least five steps. Gene knockout and heterologous expression studies have
demonstrated that at least four genes, dmaW, easF, easE, and easC, are required prior to
chanoclavine-I [6–9]. However, it is currently unknown whether these genes are sufficient to
synthesize chanoclavine-I. DMAT synthase, the product of dmaW, catalyzes the initial prenylation
reaction to yield dimethylallyltryptophan (DMAT) [6,10,11], and easF encodes a methyltransferase
that N-methylates DMAT to form the second intermediate, N-Me-DMAT [7]. The order of activity and
function of EasE and EasC have not been established, though gene knockout studies indicate these
enzymes are necessary for the conversion of N-Me-DMAT to chanoclavine-I [8,9]. Based on their
sequences, easE encodes an oxidoreductase and easC encodes a catalase. Involvement of additional
enzymes cannot be excluded because the synthesis of chanoclavine-I requires two two-electron
oxidations, and EasE is the only oxidoreductase among the four required genes. However, the eas
clusters in the diverse fungi that produce ergot alkaloids do not contain any additional conserved
oxidoreductase genes for which a function has not been assigned. Thus, the question of sufficiency of
the four required genes is unresolved.
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Aspergillus fumigatus is a common saprophytic fungus and potentially fatal pathogen in
immunocompromised individuals [12]. Ergot alkaloid synthesis genes are clustered in the
A. fumigatus genome [10,11] and are expressed during asexual reproduction [13,14].
Aspergillus nidulans, a model fungus that is closely related to A. fumigatus, does not contain the ergot
alkaloid gene cluster nor does it produce ergot alkaloids. The primary objective of this study was to
test if dmaW, easF, easC, and easE are sufficient to direct chanoclavine-I synthesis in A. nidulans.
We used a novel approach to test the sufficiency of the genes by transforming A. nidulans with
dmaW, easF, easC, and easE, or subsets of those genes, from A. fumigatus under the control of their
native promoters.
2. Results
2.1. Engineering of Chanoclavine-I Producing Strains of A. nidulans
An 8.8-kb fragment of A. fumigatus DNA containing the genes dmaW, easF, easE, and easC was
successfully amplified by PCR and integrated into the genome of two A. nidulans transformants,
yielding strains WFEC33 and WFEC35. The presence of each of the four A. fumigatus genes in the
WFEC strains was verified by PCR primed from internal gene primer-annealing sites (Figure 2). The
recipient strain A. nidulans A767 did not contain any of the four genes. The absence of the ergot
alkaloid gene cluster in A. nidulans was further supported by the lack of sequences with an E value less
than 10 in a BLASTn search between the A. fumigatus dmaW, easF, easE, and easC cluster sequence
with the genome of A. nidulans FGSC A4.
Figure 2. Ergot alkaloid synthesis genes. (a) The ergot alkaloid gene cluster of
A. fumigatus. Genes expressed in A. nidulans in this study are shown in red; (b) PCR
verification of the presence or absence of dmaW, easF, easE, and easC from wild type and
mutant strains. Each gene was independently amplified from internal primer binding sites.
Relative mobility of relevant BstEII-digested bacteriophage lambda fragments (sizes in kb)
is indicated to the left of the gel.

Both WFEC strains and A. nidulans A767 were analyzed by HPLC with fluorescence detection to
investigate the presence of ergot alkaloids. Transformed strains accumulated an analyte that co-eluted
with chanoclavine-I at approximately 33 min, whereas A. nidulans A767 did not (Figure 3). Extracts of
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WFEC35 and A. nidulans A767 also were analyzed by electrospray ionization (ESI) LC-MS in
positive mode. Again WFEC35 contained a peak that co-eluted with chanoclavine-I standard. The
analyte had an m/z of 257.1 consistent with the [M + H]+ of chanoclavine-I (Figure 4). HPLC with
fluorescence detection of mutant strain WFEC35 also revealed the presence of the early pathway
intermediate N-Me-DMAT which eluted at approximately 44 min (Figure 3). The identity of this
analyte as N-Me-DMAT was supported by an ion of m/z 287.1 in ESI LC-MS analyses (corresponding
to [N-Me-DMAT + H]+) and by co-elution with authentic standard (Figure 4).
Conidiating cultures produced modest quantities of chanoclavine-I. Aspergillus nidulans strain
WFEC35 produced approximately 0.3 fg chanoclavine-I per conidium, or about 3 ng chanoclavine-I
per mm2 of culture surface area and comparable quantities of N-Me-DMAT. Strain WFEC33 produced
lesser quantities of chanoclavine-I and did not accumulate measurable quantities of N-Me-DMAT.
Figure 3. HPLC analyses of A. nidulans strain WFEC35 (transformed with dmaW,
easF, easE, and easC), A. nidulans FGSC A767, and chanoclavine-I standard. Ch,
chanoclavine-I; N, N-Me-DMAT. Fluorescence properties were observed with an
excitation wavelength of 272 nm and an emission wavelength of 372 nm.

Figure 4. LC-MS analysis of A. nidulans extracts. Chromatograms display presence and
elution time of molecules with an m/z value of 257 ± 0.5 (left column) or 287 ± 0.5 (right
column). Chromatograms of A. nidulans strains A767 and WFEC35 were normalized to the
intensity of the highest peak in the WFEC35 trace for each analyte. The N-Me-DMAT
standard chromatogram is displayed at a higher sensitivity because of paucity of material
available. Inserts show the mass spectrum of the major peak in each chromatogram.
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2.2. Engineering of A. nidulans Strains Expressing Subsets of Early Pathway Genes
Two additional mutant strains of A. nidulans were generated by transformation with subsets of three
of the four ergot alkaloid cluster genes: strains WFC (containing dmaW, easF, and easC) and WFE
(containing dmaW, easF, and easE). The presence of each gene in the genomes of the different mutants
was verified by PCR (Figure 2). Chanoclavine-I was not detectable by HPLC (Figure 5) or ESI LC-MS
(data not shown) in either strain. Expression of dmaW and easF from the inserted construct in both
strains was validated by the accumulation of the early pathway intermediate, N-Me-DMAT, which
eluted from the column at approximately 44 min (Figure 5). In addition, WFC cultures accumulated a
novel molecule with an elution time of 41 min and that had an m/z value of 259.0 in ESI LC-MS
analyses. The unidentified metabolite displayed a higher fluorescence at excitation and emission
wavelengths of 310 nm and 410 nm, respectively, than at 272 nm excitation and 372 nm emission
settings (Figure 5). Ergot alkaloids with a double bond between carbons 9 and 10 of the ergot alkaloid
ring system fluoresce stronger at the 310 nm (excitation) and 410 nm (emission) setting compared to
their fluorescence at the 272 nm/372 nm setting; conversely, ergot alkaloids with a
8,9 double bond or those lacking a double bond at either of those positions fluoresce stronger at the
272 nm/372 nm setting [15]. The novel alkaloid was not produced in sufficient quantities to allow the
acquisition of additional structural data at this time.
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Figure 5. Fluorescence HPLC analysis of WFC and WFE mutant cultures.
(a) Chromatogram with excitation at 310 nm and emission at 410 nm; (b) Chromatogram
with excitation at 272 nm and emission at 372 nm; (c) Generic ergoline ring system with
double bond between carbons 9 and 10; (d) Generic ergoline ring system with double bond
between carbons 8 and 9. Ch, chanoclavine-I; N, N-Me-DMAT; U, Unknown unique to
strain WFC.

3. Discussion
Our results describe the first transfer of ergot alkaloid biosynthetic capability to a previously
non-producing fungus. These data also indicate that dmaW, easF, easE, and easC are sufficient for
A. nidulans to synthesize chanoclavine-I. Since the pathway leading to the formation of chanoclavine-I
appears to be evolutionarily conserved, the knowledge gained from this study will not only apply to
A. fumigatus but theoretically to all ergot alkaloid producers. Despite the large amount of research
conducted on ergot alkaloid synthesis, the formation of chanoclavine-I has yet to be completely
understood. Only two steps in this evolutionarily conserved portion of the pathway have been
completely characterized—those controlled by dmaW and easF [6,7,10,11]. After the formation of
N-Me-DMAT, the order of activity and catalytic functions of enzymes is not clear. Our data indicate
that EasE and EasC individually are necessary and together are sufficient to convert N-Me-DMAT to
chanoclavine-I. Nonetheless, the observations in this study do not rule out the possibility that
A. nidulans naturally possesses an enzyme that also contributes to the formation of chanoclavine-I
from N-Me-DMAT. Despite the fact that all known ergot alkaloid genes are clustered in A. fumigatus
and other ergot alkaloid-producing fungi [1–4,15], we cannot presently exclude the possibility
that a required gene in the pathway may be located elsewhere in the genome and common to
non-producing fungi.
Transformations with subsets of three of the four studied genes, combining alternately easC or easE
with the combination of dmaW and easF, did not yield strains capable of producing chanoclavine-I.
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These results support previous knockout data indicating that both easE and easC are required for
chanoclavine-I synthesis from N-Me-DMAT [9]. A metabolite of undetermined structure accumulated
to relatively high levels in the WFC transformant; this metabolite was not detectable in extracts of the
A. nidulans WFE strain. Improved strains or altered growth conditions will be necessary to increase
yield of the compound for the purpose of collecting adequate material for structure determination. The
WFC analyte could potentially be the next intermediate downstream of N-Me-DMAT, in which case
easC would code for the enzyme involved in the third step of ergot alkaloid synthesis. Considering its
catalase activity, one proposed function for EasC is detoxification of hydrogen peroxide produced
from the oxidative activities of EasE [9], in which case EasC would not act directly on an ergot
alkaloid substrate; however, comparison of the alkaloid profiles of WFE and WFC mutants indicates
that EasC can act independent of EasE and chemically modifies an ergot alkaloid substrate. In a
previous study, easE was knocked out in A. fumigatus, creating a strain of A. fumigatus that lacked
easE but contained easC [9]. N-Me-DMAT was detected in cultures of the easE knockout strain, but
the novel metabolite from the A. nidulans WFC strain was not observed. One potential explanation for
this apparent discrepancy is that the A. fumigatus easE knockout mutant contained downstream
enzymes in the ergot alkaloid pathway that may have altered its ergot alkaloid profile. Alternatively,
the difference between alkaloid profiles of A. fumigatus easE knockout and A. nidulans WFC could be
due to other factors in the species backgrounds in which N-Me-DMAT accumulated. It is presently
unknown whether the observed WFC analyte is an actual, on-pathway intermediate or whether it is a
byproduct of EasC acting out of sequence on a compound that is not ordinarily its substrate. Feeding
studies with the unidentified analyte and strains expressing defined sets of ergot alkaloid synthesis
genes would be a reasonable approach to test the involvement of this compound in the ergot alkaloid
pathway. Again, greater quantities of the analyte would be required for such studies. An in vitro
approach involving separate and combined enzymes also would help to fully understand the functions
of these enzymes. Difficulty with expressing EasE in active form in vitro has slowed studies of
catalytic function of this enzyme [9].
The approach of expressing genes in A. nidulans may be applied to other genes in the pathway to
study their roles in the biosynthesis of ergot alkaloids (as was recently reviewed by Chiang et al. [16]
for other fungal secondary metabolite pathways). Heterologous expression in A. nidulans also should
be applicable to studying genes from ergot alkaloid pathways of other fungi, such as those genes from
lineage-specific branches of the pathway. In such cases, it may be necessary to replace the native
promoters of those heterologous genes with promoters from A. fumigatus eas genes or strong
A. nidulans promoters.
4. Experimental Section
4.1. Fungal Strains and Growth Conditions
Aspergillus fumigatus isolate Af293, as a source of genomic DNA, was grown in malt extract broth
(15 g malt extract/L) overnight at 37 °C. The uridine auxotrophic A. nidulans isolate FGSC A767
(Fungal Genetic Stock Center, Kansas City, MO, USA) was grown at 37 °C on SYE medium
(20 g/L sucrose, 10 g/L yeast extract, 10 g/L MgSO4, 2 mL/L trace element solution [17],
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2.2 g/L uracil, 2.2 g/L uridine, with or without 15 g/L agar). For preparation of protoplasts, A. nidulans
was grown in liquid SYE medium overnight. Transformants were regenerated on selective SYE agar
medium which did not contain uracil or uridine and was supplemented with 304 g/L sucrose (to serve
as osmoticum as well as carbon source). To test alkaloid accumulation, cultures were grown on SYE
agar medium at 37 °C for one week.
4.2. DNA Manipulations
DNA was extracted from A. fumigatus according to the protocol described by Richards et al. [18].
An 8774-bp fragment containing dmaW, easF, easC, and easE was amplified by PCR primed with
oligonucleotides primer 1 (5'-TACCTATACCTAATCGAAGCCGCACGCAGTGCACC-3') and primer
2 (5'-GCCGCCCATTCACCAAGATTTTTGCACAAATCTGCG-3'). A 25 μL reaction contained 1×
LongAmp Taq reaction buffer, 200 μM of each deoxynucleotide triphosphate, 1 μM of each primer,
and 2.5 units LongAmp Taq DNA polymerase (New England BioLabs, Ipswich, MA, USA). The
reaction began with an initial denaturing step of 3 min at 94 °C, followed by 35 cycles of 30 s at 94 °C
and 10 min at 65 °C, with a final extension of 5 min at 65 °C.
A 6123-bp fragment containing dmaW, easF, and easE was amplified by PCR primed with
oligonucleotides primer 3 (5'-GAGAGCTACTTGACATATTGTGTCGGCAGGTGCGCA-3') and
primer 2 (5'-GCCGCCCATTCACCAAGATTTTTGCACAAATCTGCG-3'). The PCR conditions
were the same as stated above except the elongation time was 7 min.
In order to generate transformant WFC (containing dmaW, easF, and easC), two separate DNA
fragments were amplified for co-transformation. The first fragment containing dmaW and easC was
primed with primer 1 (5'-TACCTATACCTAATCGAAGCCGCACGCAGTGCACC-3') and primer 5
(5'-CTACTCCATTGTCCTGTGAGTTG-3') which primed amplification of a 4846-bp fragment. The
PCR conditions were the same as stated above except the elongation time was 5 min. The second
fragment (2943 bp) contained only easF and was amplified by PCR primed with oligonucleotides
easFF (5'-TCCATTCTTCGCTCGTTCAACCAGCAGG-3') and easFR (5'-CAGGACCTGTACCT
AAAGCCTGGTAACC-3') in a 25 μL reaction containing 1× GoTaq Flexi buffer, 200 μM each
deoxynucleotide triphosphate, 1.5 mM MgCl2, 1 μM of each primer, and 2.5 units of Taq DNA
polymerase (Promega, Madison, WI, USA). The reaction began with an initial denaturing step of 3 min
at 94 °C, followed by 35 cycles of 30 s at 94 °C, 30 s at 55 °C, and 3 min at 72 °C, with a final
extension of 5 min at 72 °C.
PCR products were purified with QIAquick gel extraction kits (Qiagen, Valencia, CA, USA) prior
to their inclusion in fungal transformations. The selectable marker pPyrG was obtained from the
Fungal Genetics Stock Center and was digested with XhoI (New England BioLabs, Ipswich, MA,
USA) and purified with QIAquick gel extraction kit prior to transformation.
4.3. Fungal Transformation and Screening
Protoplasts of A. nidulans FGSC A767 were prepared by incubating overnight cultures with 50 mg
driselase (Sigma-Aldrich, St. Louis, MO, USA), which was filter sterilized with a 0.22 μm filter, and
75 mg lysing enzyme (Sigma-Aldrich, St. Louis, MO, USA) in 15 mL of 0.7 M sodium chloride.
Protoplasts were purified and co-transformed with PCR product and selectable marker (pPyrG) as
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described by Coyle et al. [19]. Protoplasts were plated on SYE agar medium containing no uracil or
uridine. Transformation plates were incubated at 37 °C, and transformants were collected
approximately three days after transformation.
Each transformant was screened by PCR for the presence or absence of dmaW, easF, easC, and
easE. An internal region of dmaW was primed with dmaWF (5'-TTGATCTGGAGTGGTTCCGC-3')
and dmaWR (5'-CGTTCATGCCGAAGGTTGTG-3') yielding a 651-bp fragment. Primers for
amplifying an internal region of easE were easEF (5'-CCAGATACATTGCCATCGCATG-3') and
easER (5'-TGTTCCAACTGCTTGGCCAGAT-3'), which primed amplification of a 897-bp fragment.
The presence or absence of easC was tested by PCR with primers easCF
(5'-GAATTCGAGGTATTGATCTCC-3') and easCR (5'-AGCCAGGCAAAGATCCATAGTT-3')
which flank a 1036-bp fragment. An internal region of easF was primed with easFF
(5'-AAGTTGTCGAAGGTCTCACGAA-3') and easFR (5'-GTGATTAGAGATGCTTCTGTC-3'),
yielding an 820-bp fragment. Each of these PCRs were 25 μL reactions containing 1× GoTaq Flexi
buffer, 200 μM deoxynucleotide triphosphate, 1.5 mM MgCl2, 1 μM of each primer, and 2.5 units of
Taq DNA polymerase (Promega, Madison, WI, USA). PCR conditions began with an initial denaturing
step of 3 min at 94 °C, followed by 35 cycles of 30 s at 94 °C followed by 30 s at 55 °C, and 1 min and
30 s at 72 °C, followed by a final extension of 5 min at 72 °C.
4.4. HPLC Analyses
Transformants positive for the presence of the target genes were analyzed by HPLC for the
accumulation of chanoclavine-I. Ergot alkaloids were extracted by incubating a spore-rich sample of
the colony, containing approximately 1 cm2 of culture surface area, in 400 μL of methanol for 30 min
and clarifying the extract by centrifugation. Extracts were injected into a C18 column (Prodigy 5-μm
ODS3 (150 mm by 4.6 mm); Phenomenex, Torrance, CA, USA) and subjected to a multilinear binary
gradient from 5% (v/v) acetonitrile plus 95% (v/v) aqueous 50 mM ammonium acetate to 75%
acetonitrile plus 25% aqueous 50 mM aqueous ammonium acetate at a flow rate 1 mL/min, as
previously described [15]. Ergot alkaloids were detected using two fluorescence settings. The first
setting had an excitation wavelength of 272 nm and emission wavelength of 372 nm; the second
setting was 310 nm (excitation) and 410 nm (emission). Chanoclavine-I (generously provided by Brian
Tapper, AgResearch, New Zealand) and N-Me-DMAT (gift from Sarah O’Connor, University of East
Anglia) were run as standards. Peaks of interest were isolated from the HPLC by collecting the runoff
from the discard tube for 30 s after the peak was visualized on the detector.
4.5. LC-MS Analyses
Ergot alkaloid extracts were prepared by washing the surface of a conidiating colony with 2 mL of
methanol, rotating the extract at 30 rpm for 30 min, and then clarifying the extract by centrifugation.
Clarified extracts were then concentrated to a volume of 50 μL in a speed-vac apparatus, and 10 μL of
concentrated extract were injected into the LC-MS. To isolate individual analytes, concentrated
extracts were analyzed by fluorescence HPLC, peaks were collected manually, and concentrated to a
volume of 50 μL in a speed-vac apparatus prior to LC-MS analysis. Concentrated samples were
analyzed on a Finnigan LCQDecaXP plus mass spectrometer equipped with a Surveyor HPLC system.
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Analytes were separated on a C18 column (Phenomenex 4-μm polar-RP (150 mm by 2 mm)),
maintained at 30 °C, by combining mobile phases A (5% acetonitrile, 0.1% formic acid) and B (75%
acetonitrile, 0.1% formic acid). Initial conditions were 86% A + 14% B, which ramped linearly to 73%
A + 27% B at 25 min, 25% A + 75% B at 40 min, and 0% A + 100% B at 42 min. The flow rate was
200 μL/min. Analytes were ionized by electrospray ionization in positive mode and were detected by
scanning for ions with a m/z between 200–400.
5. Conclusions
Four genes common to all ergot alkaloid synthesis gene clusters—dmaW, easF, easE, and
easC—are sufficient to direct synthesis of chanoclavine-I in A. nidulans. Both easC and easE are
required for the synthesis of chanoclavine-I from N-Me-DMAT, but neither alone is sufficient.
Aspergillus nidulans is a suitable heterologous host for expressing ergot alkaloids synthesis genes.
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